These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34830706)

  • 1. Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies.
    Sriboonvorakul N; Pan-Ngum W; Poovorawan K; Muangnoicharoen S; Quinn LM; Tan BK
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors.
    Wang M; Ou Y; Yuan XL; Zhu XF; Niu B; Kang Z; Zhang B; Ahmed A; Xing GQ; Su H
    World J Diabetes; 2024 Jan; 15(1):53-71. PubMed ID: 38313852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus.
    Ikeda H
    J Diabetes Res; 2022; 2022():2048300. PubMed ID: 35734236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.
    Piccolo BD; Graham JL; Stanhope KL; Fiehn O; Havel PJ; Adams SH
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E958-69. PubMed ID: 27094034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus.
    Walford GA; Davis J; Warner AS; Ackerman RJ; Billings LK; Chamarthi B; Fanelli RR; Hernandez AM; Huang C; Khan SQ; Littleton KR; Lo J; McCarthy RM; Rhee EP; Deik A; Stolerman E; Taylor A; Hudson MS; Wang TJ; Altshuler D; Grant RW; Clish CB; Gerszten RE; Florez JC
    Metabolism; 2013 Dec; 62(12):1772-8. PubMed ID: 23953891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness.
    Wolak-Dinsmore J; Gruppen EG; Shalaurova I; Matyus SP; Grant RP; Gegen R; Bakker SJL; Otvos JD; Connelly MA; Dullaart RPF
    Clin Biochem; 2018 Apr; 54():92-99. PubMed ID: 29432757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry.
    Sriboonvorakul N; Pan-Ngum W; Poovorawan K; Winterberg M; Tarning J; Muangnoicharoen S
    Int Health; 2021 Jul; 13(4):367-373. PubMed ID: 33118019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of Vitamin D Serum Levels in Patients with Type Two Diabetes Mellitus Reduces Levels of Branched Chain Amino Acids.
    Alfaqih MA; Melhem NY; F Khabour O; Al-Dwairi A; Elsalem L; Alsaqer TG; Allouh MZ
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
    Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.
    Del Coco L; Vergara D; De Matteis S; Mensà E; Sabbatinelli J; Prattichizzo F; Bonfigli AR; Storci G; Bravaccini S; Pirini F; Ragusa A; Casadei-Gardini A; Bonafè M; Maffia M; Fanizzi FP; Olivieri F; Giudetti AM
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31117294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications.
    Tanase DM; Gosav EM; Botoc T; Floria M; Tarniceriu CC; Maranduca MA; Haisan A; Cucu AI; Rezus C; Costea CF
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
    Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
    Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study.
    Preiss D; Rankin N; Welsh P; Holman RR; Kangas AJ; Soininen P; Würtz P; Ala-Korpela M; Sattar N
    Diabet Med; 2016 Nov; 33(11):1569-1574. PubMed ID: 26887663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
    Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
    Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive association of branched-chain amino acids with triglyceride and glycated haemoglobin in Indian patients with type 2 diabetes mellitus.
    Sankanagoudar S; Shukla R; Shukla KK; Sharma P
    Diabetes Metab Syndr; 2022 Apr; 16(4):102481. PubMed ID: 35427914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caloric restriction improves glycaemic control without reducing plasma branched-chain amino acids or keto-acids in obese men.
    Sayda MH; Abdul Aziz MH; Gharahdaghi N; Wilkinson DJ; Greenhaff PL; Phillips BE; Smith K; Idris I; Atherton PJ
    Sci Rep; 2022 Nov; 12(1):19273. PubMed ID: 36369511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.
    McCormack SE; Shaham O; McCarthy MA; Deik AA; Wang TJ; Gerszten RE; Clish CB; Mootha VK; Grinspoon SK; Fleischman A
    Pediatr Obes; 2013 Feb; 8(1):52-61. PubMed ID: 22961720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Effects of Branched-Chain Amino Acids-Enriched Dialysis Fluid on Branched-Chain Amino Acids Plasma Level and Mass Balance: A Randomized Cross-Over Study.
    Deleaval P; Luaire B; Laffay P; Jambut-Cadon D; Stauss-Grabo M; Canaud B; Chazot C
    J Ren Nutr; 2020 Jan; 30(1):61-68. PubMed ID: 31078402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.